Convey Holding Parent, Inc., together with its subsidiaries, provides technology enabled solutions and advisory services to assist its clients with workflows across product developments, sales, member experience, clinical management, core operations, and business intelligence and analytics in the United States. It operates through two segments, Technology Enabled Solutions and Advisory Services. The Technology Enabled Solutions segment offers technology solutions through web-based customizable application that is used to identify, track, and administer contractual services, or benefits provided under a client's plan to its Medicare and Medicaid beneficiaries. It also provides analytics over healthcare data to capture and assess gaps in risk documentation, quality, clinical care, and compliance. The company's software solutions for health plans include enrollment and billing technology, supplemental benefits solution, agent and broker management, membership and financial reconciliation, compliance monitoring, and data analytic solutions. The Advisory Services segment offers advisory services, including sales and marketing strategies, provider network strategies, compliance, star ratings, quality, clinical, pharmacy, analytics, and risk adjustment. The company serves government sponsored, medicare, medicaid, and provided sponsored plans, as well as pharmacy benefits managers. The company was founded in 2001 and is headquartered in Fort Lauderdale, Florida. Convey Holding Parent, Inc. is a subsidiary of TPG Cannes Aggregation, L.P.
IPO Year: 2021
Exchange: NYSE
Website: conveyhealthsolutions.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/7/2022 | $12.00 | Buy | Guggenheim |
| 2/11/2022 | $10.00 | Neutral | Goldman |
| 7/12/2021 | $18.00 | Buy | Canaccord Genuity |
| 7/12/2021 | $16.00 | Buy | Truist Securities |
| 7/12/2021 | $21.00 | Buy | Goldman |
| 7/12/2021 | $15.00 | Buy | BofA Securities |
| 7/12/2021 | $16.00 | Overweight | Barclays |
| 7/12/2021 | $12.00 | Neutral | JP Morgan |
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)
4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)
4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)
4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)
4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)
4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)
4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)
4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)
4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)
4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Guggenheim initiated coverage of Convey Health with a rating of Buy and set a new price target of $12.00
Goldman initiated coverage of Convey Health with a rating of Neutral and set a new price target of $10.00
Canaccord Genuity initiated coverage of Convey Health with a rating of Buy and set a new price target of $18.00
Truist Securities initiated coverage of Convey Holding Parent with a rating of Buy and set a new price target of $16.00
Goldman initiated coverage of Convey Health with a rating of Buy and set a new price target of $21.00
BofA Securities initiated coverage of Convey Health with a rating of Buy and set a new price target of $15.00
Barclays initiated coverage of Convey Holding Parent with a rating of Overweight and set a new price target of $16.00
JP Morgan initiated coverage of Convey Holding Parent with a rating of Neutral and set a new price target of $12.00
15-12G - Convey Health Solutions Holdings, Inc. (0001787640) (Filer)
S-8 POS - Convey Health Solutions Holdings, Inc. (0001787640) (Filer)
S-8 POS - Convey Health Solutions Holdings, Inc. (0001787640) (Filer)
SC 13E3/A - Convey Health Solutions Holdings, Inc. (0001787640) (Subject)
25-NSE - Convey Health Solutions Holdings, Inc. (0001787640) (Subject)
8-K - Convey Health Solutions Holdings, Inc. (0001787640) (Filer)
SC 13E3/A - Convey Health Solutions Holdings, Inc. (0001787640) (Subject)
DEFM14C - Convey Health Solutions Holdings, Inc. (0001787640) (Filer)
PRER14C - Convey Health Solutions Holdings, Inc. (0001787640) (Filer)
SC 13E3/A - Convey Health Solutions Holdings, Inc. (0001787640) (Subject)
Fastest customizable press release news feed in the world
Convey Taken Private by TPG for $10.50 per Share in Cash FORT LAUDERDALE, Fla., Oct. 7, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey"), a leading healthcare technology and services company, announced today the closing of its acquisition by TPG Capital, the large-scale U.S. and European private equity platform of alternative asset management firm TPG. On June 21, 2022, Convey announced that TPG Capital had signed a definitive agreement to acquire all of the outstanding shares of Convey common stock not currently owned by TPG or certain manage
Convey Shareholders to Receive $10.50 per Share in Cash, Representing a 99% Premium Over Convey's 30-Day Volume Weighted Average Price FORT LAUDERDALE, Fla., June 21, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey"), a leading healthcare technology and services company, announced today that it has entered into a definitive merger agreement pursuant to which TPG Capital, the private equity platform of global alternative asset management firm TPG ("TPG") and Convey's principal shareholder, will acquire all of the outstanding shares of Convey common stock not currently owned by TPG or certain management and director shareholders for $10.50 per share in cash, re
First Quarter 2022 Highlights Net revenues of $96.7 million, up 17% compared to Q1 2021 of $82.6 millionNet loss of $1.2 million, which includes $1.6 million of HealthSmart purchase accounting and acquisition related expenses, compared to Q1 2021 net loss of $0.9 millionAdjusted EBITDA of $15.3 million, compared to Q1 2021 of $15.9 millionFORT LAUDERDALE, Fla., May 10, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) (the "Company" or "Convey"), a leading healthcare technology and services company in the U.S., announced today financial results for the first quarter ended March 31, 2022.
FORT LAUDERDALE, Fla., May 3, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey Health Solutions" or "Convey"), a leading healthcare technology and services company, announced today that it will issue a press release with first quarter 2022 financial results on Tuesday, May 10, 2022 after the market closes. In conjunction with the release, Convey will host a conference call to review these financial results at 4:30 p.m. (ET) on the same day. First Quarter 2022 Conference Call Details The conference call can be accessed by dialing (844) 200-6205 for U.S. participants, or +1 (929) 526-1599 for international participants, referencing access code 105506; or via a l
Provides 2022 Guidance Fourth Quarter 2021 Highlights Net revenues of $97.3 million, up 12% compared to Q4 2020Net income of $0.4 million, compared to net income of $8.1 million in Q4 2020 which included a one-time benefit of $10.8 million due to the valuation of certain earn-out paymentsAdjusted EBITDA or AEBITDA of $19.9 million, up 3% compared to Q4 2020. Q4 2021 included previously announced one-time implementation costs related to a new client winFull Year 2021 Highlights Net revenues of $337.6 million, up 19% compared to prior yearNet loss of $10.0 million which included $18.0 million of one-time costs related to the IPO, compared to net loss of $6.5 million in prior year which includ
FORT LAUDERDALE, Fla., Feb. 23, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey Health Solutions" or "Convey"), a leading healthcare technology and services company, announced today that it will issue a press release with fourth quarter and full year 2021 financial results and 2022 guidance on Wednesday, March 23, 2022 after the market closes. In conjunction with the release, Convey will host a conference call to review these financial results at 5:00 p.m. (ET) on the same day. Fourth Quarter and Full Year 2021 Conference Call Details The confe
FORT LAUDERDALE, Fla., Feb. 15, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey"), a leading healthcare technology and services company, today announced the appointment of Paul Campanelli to its Board of Directors ("Board"). Mr. Campanelli has approximately 30 years of experience in the healthcare industry, including leadership positions in both publicly held and private equity controlled companies. Mr. Campanelli previously served as Chairman of the Board of Endo International ("Endo") from November 2019 to June 2021, and previously served as
FORT LAUDERDALE, Fla., Feb. 1, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) (Convey), a leading healthcare technology and services company, announced today that it completed the previously announced acquisition of HealthSmart International (www.livehealthsmart.com). The acquisition enhances Convey's ability to provide best-in-class services to the nation's top health plans, pairing HealthSmart's diverse portfolio of health, wellness and diagnostic products centered on home-based care with Convey's innovative supplemental benefits offering to enable
FORT LAUDERDALE, Fla., Jan. 10, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) (Convey), a leading healthcare technology and services company, announced today that it entered into a definitive agreement to acquire HealthSmart International (HealthSmart) for $77.5 million in cash. The transaction is subject to customary closing conditions, with up to $15 million of additional cash payable if HealthSmart achieves certain 2022 revenue targets. The acquisition of HealthSmart (https://www.livehealthsmart.com) will further expand Convey's mission to provide industry leading solutions and services that improve health plan operations and elevate the member experience. The pa
FORT LAUDERDALE, Fla., Jan. 4, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey"), a leading healthcare technology and services company, announced today that Stephen Farrell, Chief Executive Officer, Tim Fairbanks, Chief Financial Officer, and John Steele, Executive Vice President, Technology, will participate in the 40th Annual J.P. Morgan Healthcare Conference including a virtual fireside chat presentation at 9:45 a.m. (ET) on Tuesday, January 11, 2022. The live audio webcast of the fireside chat presentation will be available on the "Events
Live Leadership Updates
FORT LAUDERDALE, Fla., Feb. 15, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey"), a leading healthcare technology and services company, today announced the appointment of Paul Campanelli to its Board of Directors ("Board"). Mr. Campanelli has approximately 30 years of experience in the healthcare industry, including leadership positions in both publicly held and private equity controlled companies. Mr. Campanelli previously served as Chairman of the Board of Endo International ("Endo") from November 2019 to June 2021, and previously served as
Live finance-specific insights
First Quarter 2022 Highlights Net revenues of $96.7 million, up 17% compared to Q1 2021 of $82.6 millionNet loss of $1.2 million, which includes $1.6 million of HealthSmart purchase accounting and acquisition related expenses, compared to Q1 2021 net loss of $0.9 millionAdjusted EBITDA of $15.3 million, compared to Q1 2021 of $15.9 millionFORT LAUDERDALE, Fla., May 10, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) (the "Company" or "Convey"), a leading healthcare technology and services company in the U.S., announced today financial results for the first quarter ended March 31, 2022.
FORT LAUDERDALE, Fla., May 3, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey Health Solutions" or "Convey"), a leading healthcare technology and services company, announced today that it will issue a press release with first quarter 2022 financial results on Tuesday, May 10, 2022 after the market closes. In conjunction with the release, Convey will host a conference call to review these financial results at 4:30 p.m. (ET) on the same day. First Quarter 2022 Conference Call Details The conference call can be accessed by dialing (844) 200-6205 for U.S. participants, or +1 (929) 526-1599 for international participants, referencing access code 105506; or via a l
FORT LAUDERDALE, Fla., Feb. 23, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey Health Solutions" or "Convey"), a leading healthcare technology and services company, announced today that it will issue a press release with fourth quarter and full year 2021 financial results and 2022 guidance on Wednesday, March 23, 2022 after the market closes. In conjunction with the release, Convey will host a conference call to review these financial results at 5:00 p.m. (ET) on the same day. Fourth Quarter and Full Year 2021 Conference Call Details The confe
FORT LAUDERDALE, Fla., Oct. 27, 2021 /PRNewswire/ -- Convey Holding Parent, Inc. (NYSE:CNVY) ("Convey Health Solutions" or "Convey"), a leading healthcare technology and services company, announced today that it will release fiscal third quarter 2021 financial results on Wednesday, November 10, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day. Third Quarter 2021 Conference Call Details The conference call can be accessed by dialing (844) 200-6205 for U.S. participants, or + 44 208-0682-558
FORT LAUDERDALE, Fla., July 29, 2021 /PRNewswire/ -- Convey Holding Parent, Inc. (NYSE:CNVY) ("Convey Health Solutions" or "Convey"), a leading healthcare technology and services company, announced today that it will release fiscal second quarter 2021 financial results on Thursday, August 12, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day. Conference Call DetailsThe conference call can be accessed by dialing (844) 200-6205 for U.S. participants, or + 44 208-0682-558 for international par
This live feed shows all institutional transactions in real time.
SC 13G/A - Convey Health Solutions Holdings, Inc. (0001787640) (Subject)